首站-论文投稿智能助手
典型文献
Application of the Phase Angle in Patients with Malignant Tumors
文献摘要:
Bioelectrical impedance analysis(BIA)is a noninvasive and reproducible technique for assessing changes in body composition and nutritional status.The phase angle(PA),a major parameter of BIA,is one of the most sensitive indicators used to detect malnutrition in patients,and is also a prognostic marker in various clinical diseases.The incidence of malnutrition in cancer patients is high,and malnutrition seriously affects the treatment process and prognosis of patients.Reasonable and effective nutritional interventions are therefore of great significance for cancer patients.Compared with traditional nutritional assessment tools,the PA has unique advantages in the nutritional assessment,efficacy monitoring and prognostic prediction of patients with malignant tumors,and it has broad application prospects in clinical practice.This article reviews the research progress on the application of the PA in patients with malignant tumors to provide clinicians with a tool to predict malnutrition,and provide a more favorable basis for the nutritional assessment,treatment and prognostic prediction of cancer patients.
文献关键词:
作者姓名:
Xue Lian Ma;Jian Hua Deng;Xian Xu Su;Hui Wang
作者机构:
Department of Oncology,The People's Hospital of Dujiangyan,Dujiangyan,Sichuan 611830,China;Department of Thoracic Surgery,The People's Hospital of Dujiangyan,Dujiangyan,Sichuan 611830,China
引用格式:
[1]Xue Lian Ma;Jian Hua Deng;Xian Xu Su;Hui Wang-.Application of the Phase Angle in Patients with Malignant Tumors)[J].肿瘤营养学杂志(英文),2022(04):161-174
A类:
Bioelectrical
B类:
Application,Phase,Angle,Patients,Malignant,Tumors,impedance,analysis,BIA,noninvasive,reproducible,technique,assessing,changes,body,composition,nutritional,status,phase,angle,PA,major,parameter,one,most,sensitive,indicators,used,detect,malnutrition,patients,also,prognostic,marker,various,clinical,diseases,incidence,cancer,high,seriously,affects,treatment,process,prognosis,Reasonable,effective,interventions,therefore,great,significance,Compared,traditional,assessment,tools,unique,advantages,efficacy,monitoring,prediction,malignant,tumors,broad,application,prospects,practice,This,article,reviews,research,progress,provide,clinicians,more,favorable,basis
AB值:
0.544473
相似文献
Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma:Integrating Bioinformatics and Clinical Analyses
Xing WEI;Qing-mei ZHANG;Chang LIU;Song WU;Wei-xia NONG;Ying-ying GE;Li-na LIN;Feng LI;Xiao-xun XIE;Bin LUO-Department of Histology and Embryology,School of Pre-clinical Medicine,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Central Laboratory of Pre-Clinical Medicine(Key Laboratory of Guangxi Colleges and Universities),Guangxi Medical University,Nanning 530021,China;Department of Neurosurgery,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China
High Expression of Fibronectin 1 Predicts a Poor Prognosis in Glioblastoma
Song WU;Chang LIU;Xing WEI;Wei-xia NONG;Li-na LIN;Feng LI;Xiao-xun XIE;Xing-sheng LIAO;Bin LUO;Qing-mei ZHANG;Shao-wen XIAO-Department of Neurosurgery,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Department of Histology and Embryology,School of Pre-clinical Medicine,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China;Central Laboratory of Pre-Clinical Medicine(Key Laboratory of Guangxi Colleges and Universities),Guangxi Medical University,Nanning 530021,China
A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province,China
Jiaojiao Xie;Ding Shi;Mingyang Bao;Xiaoyi Hu;Wenrui Wu;Jifang Sheng;Kaijin Xu;Qing Wang;Jingjing Wu;Kaicen Wang;Daiqiong Fang;Yating Li;Lanjuan Li-State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;State Key Laboratory of Genetic Engineering,Institute of Biostatistics,School of Life Sciences,Fudan University,Shanghai 200433,China;Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,Key Lab of Combined Multi-organ Transplantation of the Ministry of Health,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China;Division of of Endocrinology and Metabolism,Department of Internal Medicine System,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China
A Novel Diagnostic and Therapeutic Strategy for Cancer Patients by Integrating Chinese Medicine Syndrome Differentiation and Precision Medicine
YU Shu-xian;LIANG Zi-mao;WU Qi-biao;SHOU Lan;HUANG Xing-xing;ZHU Qian-ru;XIE Han;MEI Ru-yi;ZHANG Ruo-nan;ZHAI Xiang-yang;XIE Tian;SUI Xin-bing-School of Pharmacy and Department of Medical Oncology,the Affiliated Hospital of Hangzhou Normal University,College of Medicine,Hangzhou Normal University,Hangzhou 311121,China;Key Laboratory of Elemene Class Anti-cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province,Hangzhou Normal University,Hangzhou 311121,China; State Key Laboratory of Quality Research in Chinese Medicines,Faculty of Chinese Medicine,Macau University of Science and Technology,Macau,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。